Company
Headquarters: New Taipei City, Taiwan
TW$13.79 Billion
TWD as of Jan. 1, 2024
US$449.3 Million
| Company | Market Cap (USD) |
|---|---|
| Abbott | $192.67 B |
| Stryker Corporation | $113.24 B |
| Medtronic | $111.60 B |
| Boston Scientific Corporation | $85.22 B |
| Shenzhen Mindray Bio-Medical Electronics Co. Ltd | $49.33 B |
| Company | Market Cap (USD) |
|---|---|
| Lilly | $586.39 B |
| UnitedHealth Group | $504.47 B |
| Novo Nordisk | $461.52 B |
| Johnson & Johnson | $387.50 B |
| Merck | $296.51 B |
Excelsior Medical Co., Ltd. distributes medical related systems in Taiwan, China, Japan, Korea, Malaysia, and the Philippines. The company offers equipment for hemodialysis, regular drug used in the medical institution, surgical equipment, and medical assistant electronics; and cosmetic equipment. It also provides medical administration services for single department. The company was founded in 1988 and is based in New Taipei City, Taiwan.
Top 1-year algo backtest: +269.94%
$10,000 in May 2023 would now be $36,994 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
Excelsior Medical Co. Ltd has the following listings and related stock indices.
Stock: TWSE: 4104 wb_incandescent